Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated ...

Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...

A commonly used antibiotic called vancomycin, which is usually prescribed to treat infectious diarrhea, may also be helpful ...

Crohns disease is a chronic Inflammatory Bowel Disease IBD which produces persistent irritation of the gastrointestinal tract ...

Last February, Pliant Therapeutics released 12-week interim data from the 320 mg dose group of INTEGRIS-PSC Phase 2a trial of ...

Moreover, IBD and PSC are closely correlated ... Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel ...

potentially the first FDA-approved treatment for primary sclerosing cholangitis (PSC). The company's stock has shown remarkable strength, delivering a 206.4% return over the past year, according ...

The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

potentially the first FDA-approved treatment for primary sclerosing cholangitis (PSC). The company's stock has shown remarkable strength, delivering a 206.4% return over the past year, according to ...